Literature DB >> 9577313

Surgical reconstruction in cryptophthalmos.

C J Weng1.   

Abstract

Cryptophthalmos is the congenital absence of the eyelid with skin passing continuously from the forehead onto the cheek over a malformed eye. The deformity can be classified into three types: complete, incomplete and abortive. We present the cases of two siblings, each with incomplete cryptophthalmos involving one eye. We report a three-stage reconstructive procedure in which a conchal cartilage 'sandwich' graft was first placed between the skin flap and the globe, mucous membrane subsequently grafted onto the inner surface of the cartilage graft, and lid level adjusted as the third stage.

Entities:  

Mesh:

Year:  1998        PMID: 9577313     DOI: 10.1054/bjps.1997.0167

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  5 in total

1.  Cryptophthalmos.

Authors:  S Kanhere; V Phadke; A Mathew; S F Irani
Journal:  Indian J Pediatr       Date:  1999 Sep-Oct       Impact factor: 1.967

Review 2.  Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes.

Authors:  A M Slavotinek; C J Tifft
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

Review 3.  Congenital upper eyelid coloboma: embryologic, nomenclatorial, nosologic, etiologic, pathogenetic, epidemiologic, clinical, and management perspectives.

Authors:  Hatem A Tawfik; Mohamed H Abdulhafez; Yousef A Fouad
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Jan-Feb       Impact factor: 1.746

Review 4.  Clinical features and orbital anomalies in Fraser syndrome and a review of management options.

Authors:  Deepsekhar Das; Sujeeth Modaboyina; Sandton Raj; Sahil Agrawal; Mandeep Singh Bajaj
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

5.  Novel surgical technique for the management of partial cryptophthalmos.

Authors:  Ramesh Murthy; Himika Gupta
Journal:  Indian J Ophthalmol       Date:  2014-11       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.